NUC Upgrades Bachelor of Physiotherapy Programme to Doctor of Physiotherapy

The National Universities Commission (NUC) has upgraded the programme and curriculum of Bachelor of Physiotherapy/Bachelor of Medical Rehabilitation, which was a five year programme to Doctor of physiotherapy, now a six years programme.

The introduction of the new curriculum is contained in a recent circular jointly signed by the Registrar, Medical Rehabilitation Therapists (Registration) Board of Nigeria (MRTB) Dr (Mrs) Olufunke Taibat Akanle and Board Chairman, Dr (Mrs) Umo Edet Udom, addressed to all vice-chancellors, provosts, dean of faculties, and heads of departments of all tertiary institutions in the country.

The Registrar explained the essence of the adjustment was to raise practice standards in the profession as well as to meet knowledge and skills gap in the management of current prevailing non-communicable diseases.

“I write on behalf of the Medical Rehabilitation Therapists (Registration) Board of Nigeria (MRTB), established by degree 38 of 1988/Acts M9 LFN 2004, for the regulation and control of training and practice of Physiotherapy, Occupational Therapy, Speech Therapy, Audiology, Prosthetics and Orthotics, Chiropractic and Osteopathic Medicine in the health sector in Nigeria to formally draw your attention to the approval of the commencement of Doctor of Physiotherapy training (DPT) in Nigeria and hence to introduce to all the existing academic institutions running Physiotherapy training programme and institutions interested in running Physiotherapy programme to the upgrading of Bachelor of Physiotherapy (BPT) programme  to DPT.

“This is in line with our statutory function of determining the standards to meet with the knowledge and skills demand in the management of current prevailing non-communicable diseases, and scale up all the necessary areas of specialisation that are needed to equip our students for the task ahead. Also to raise the standards of training of Physiotherapy in Nigeria to meet best practices”, she stated.

Although the NUC had earlier notified the MRTB Registrar on the conclusion of the upgrading exercise about three years ago, but it appears the circular was not delivered until recently.

In a circular dated 21 June 2018, signed by Director, Academic Planning Dr G.B Kumo, on behalf of the Executive Secretary, NUC, the conclusion of processes for the review of the curriculum of Bachelor of Physiotherapy to Doctor of Physiotherapy was confirmed, and 10 copies of the approved Benchmark Minimum Academic Standards (BMAS) were stated to have been sent to the MRTB.

The Executive Secretary wrote: “I am directed to appreciate the Registrar/CEO and the MRTB for partnering with the Commission in sponsoring the review and upgrading of BMAS for the B.Sc Physiotherapy/B.Sc Medical Rehabilation Programme (5 years) to Doctor of Physiotherapy (6 Years).

“I am to confirm that the review/upgrading exercise has been concluded successfully and ten copies of the finalized BMAS for Doctor of Physiotherapy are hereby forwarded to the MRTB for its information”, he stated.

Credit: NUC Upgrades Bachelor of Physiotherapy to Doctor of Physiotherapy (pharmanewsonline.com)

Step-by-Step Guide to New Zealand to Australia Nurse Registration

Welcome to this comprehensive guide on the easiest way to migrate to Australia as a foreign educated/overseas nurse through the New Zealand Nursing Board. I am going to take you hand in hand through the registration process.

Australia Nursing Board introduced the new Stream and OBA route which makes direct registration as an overseas nurses super expensive. The easiest and cheapest route is through the New Zealand Board of Nursing. You first apply and get registered as a nurse in New Zealand then you simply endorse it to Australia. Let get started!

Requirements:

Below are the requirements needed before you can start the registration process:

  1. A Bachelor degree in Nursing (Nursing Certificate is now allowed)
  2. Two forms of identity cards usually your international passport and any other government issued identity card. You will need to make photocopies of these documents and notarized the photocopy. Then you will need to upload the notarized copy.
  3. Proof of English Proficiency (IELTS/OET): Academic IELTS with a score of 7 in each band. You can club/combine IELTS provided you sat for both IELTS within 6 months apart and no score is less than 6.5. You must however still have a score of 7 in all modules even when combine IELTS. If you had your Nursing education in USA, UK, Canada and Ireland or you are currently a registered Nurse in any of the listed countries, English language will be waived for you.

Note: IELTS for New Zealand Nurse registration is valid for 3 years and not 2 years like other countries.

4. At least a minimum of two (2) years work experience within the last five years. If you have worked in UK, USA, Canada or Ireland you will be registered directly and won’t need to undergo the 6 to 12 weeks adaptation course.

Step-by-Step Guide

Step 1: Gather the above requirement especially notarization of your passport and ID card

Step 2: Create an account with New Zealand CGFNS by going to the link Register (force.com)

Step 3: Complete the CGFNS Application form. You can apply for English waiver if you are practicing as a Nurse in one of the aforementioned countries at this stage. See the guide on how to complete CGFNS Application form. Note: if you have an account with USA CGFNS for NCLEX purpose, you can ask CGFNS New Zealand to help you import your transcripts and verification into your profile so you won’t need to send another verification.

Step 4: Make payment for your CGFNS application. This cost $300 (Exchange rate varies if you are using your local card).

Step 5: Receive a mail from CGFNS confirming your payment and informing you to wait for 2-3 days before your forms are available for download. After few hours or a day, you should receive an email from CGFNS that your application has been approved and you can now proceed to download your forms and send it to the appropriate quarters.

For Step-by-Step Guide to creation of account with CGFNS for New Zealand Board of Nurse Registration, Read How To Create CGFNS Account For New Zealand Nursing Board

You should also read How To Request For Verification With UK NMC

Stop the Lies, UK Does Not Stop Recruitment of Overseas Nurses, Doctors

Has UK stopped the recruitment of foreign doctors and nurses into the NHS or Care Homes? The answer is simple and it is NO! Below is an explanation of the rumours going round the social media space.

On February 26, 2021, the UK government updated the guideline on the recruitment of overseas Nurses and doctors and ever since then there has been misinterpretation of the guideline by various blogs and invdiduals. The new guideline forbid the active recruitment of health workers from resource constraints countries. Part of the Guideline reads:

Read also How To Be A Registered Nurse in UK in 2021 – Types of Nursing: Nursing News, Jobs, Opportunities

UK recruiters are not permitted to actively recruit from these countries unless there is a government to government agreement in place for managed recruitment.

These countries are:Afghanistan

Angola

Bangladesh

Benin

Burkina Faso

Burundi

Cameroon

Central African Republic

Chad

Congo

Congo, Democratic Republic of

Côte d’Ivoire

Djibouti

Equatorial Guinea

Eritrea

Ethiopia

Gabon

Gambia, The

Ghana

Guinea

Guinea-Bissau

Haiti

Kiribati

Lesotho

Liberia

Madagascar

Malawi

Mali

Mauritania

Micronesia, Federated States of

Mozambique

Nepal

Niger

Nigeria

Pakistan

Papua New Guinea

Senegal

Sierra Leone

Solomon Islands

Somalia

South Sudan

Sudan

Tanzania, United Republic of

Togo

Uganda

Vanuatu

Yemen, Republic of

While this may look new to many people who are seeing it for the first time, the truth is this has been in existence for ages and usually reviewed every three years (3). This latest edition is the new review of the 2019 guideline.

UK position is in tandem with the World Health Organization policy popularly called the Kampala Declaration. It was a joint decision for WHO member States not to actively recruit health workers from poor countries. This declaration came to force in 2008 and member countries such as UK has been implementing this guideline. You can download the WHO Guideline on Recruitment of Health Workers from WHO_HSS_HRH_HMR_2010.2_eng.pdf;jsessionid=E5A5614DF24BB2AD1F9BFB6394D10843

UK employers have not been doing active recruitment of Nurses and doctors in poor countries listed above over a decade. What they do is passive recruitment of Nurses from those countries.

Active recruiting means UK employers flying down to those countries on the red list and offering the Nurses a job after conducting physical interview like they do in Philippines and India.

Passive recruiting on the other hand means UK employers set up a website and advertise their jobs online on a UK website such as NHS job portal NHS Jobs – Candidate Homepage , trac.jobs , Care Home Jobs UK – UK Care Home Job Vacancies etc and applicants applying online, attend interview online etc As long as UK employer doesn’t board a plane and come into your country to recruit the applicants, that is called passive recruitment which is allowed by the UK government. This is how UK employers have been recruiting from countries on the red list without violating the WHO guideline.

You might be interested in Things To Know Before Taking AstraZeneca COVID 19 Vaccine – Types of Nursing: Nursing News, Jobs, Opportunities

Below are example of cases of what constitutes active recruitment and passive recruitment released by UK government on it website:

The following case studies show recruitment activity in breach of the code of practice.

Case study 1

An agency advertises within a red country on the list and actively supports several candidates from that country with their applications, appointments and travel to the UK. This would be deemed active recruitment and contravenes the guiding principles within the code of practice.

Case study 2

An agency runs a recruitment fair in Nigeria highlighting opportunities in the UK. Nigeria is on the list and should not be actively targeted for recruitment. The agency does not actually hire anyone. This would still be deemed active recruitment and contravenes the guiding principles within the code of practice.

Case study 3

An agency or organisation with multinational contracts advertises in Uganda. They highlight that they are recruiting to a different country (that is, not the UK), however they also have contracts in the UK. It later transpires that the agency facilitated a candidate’s arrival to work in the UK. This would still be deemed active recruitment and contravenes the guiding principles within the code of practice.

Case study 4

A recruitment agency is approached by an individual working in a country on the list who has been referred to the agency by their friend who is working as a social care nurse in the UK. The agency supports the individual with their application and makes a bonus payment to their friend for the referral. This is in breach of the code of practice, an agency should not facilitate the recruitment process unless the candidate has already been appointed by the employer through a direct application. In addition, referral fee schemes are deemed to be active recruitment and are not permitted in countries on the list.

The following case studies show acceptable recruitment activity under the code of practice.

Case study 5

A nurse from Sudan applies to work in the NHS unassisted. He is interviewed by the trust and deemed successful for the post, subsequently travelling to the UK on receipt of his visa. This activity did not include any active recruitment therefore does not contravene the code of practice.

Case study 6

A doctor from Nepal is working in Canada having relocated there five years ago. An agency advertises in Canada and the doctor is picked up in the cohort and wishes to come to the UK. This activity is not in breach of the code of practice; ethical recruitment is determined by the country from which the individual is being recruited, rather than the nationality of the individual.

Case study 7

A nurse from Pakistan applies directly to a social care employer in the UK and is successfully appointed. The social care employer requires the support of a recruitment agency to facilitate the nurse through the remaining part of the recruitment process. This activity is not in breach of the code of practice.

Don’t forget to share with your friends and colleagues

Things To Know Before Taking AstraZeneca COVID 19 Vaccine

The UK Government published the following information about the AstraZeneca COVID 19 vaccine on her website for anyone who want to take the vaccine should go through. Below is the full information you need to know about the vaccine:

This medicinal product has been given authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency. It does not have a marketing authorisation, but this temporary authorisation grants permission for the medicine to be used for active immunisation of individuals aged 18 years and older for the prevention of coronavirus disease 2019 (COVID-19).

Reporting of side effects

As with any new medicine in the UK this product will be closely monitored to allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.

Read all of this leaflet carefully before the vaccine is given because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist or nurse.
  • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

  1. What COVID-19 Vaccine AstraZeneca is and what it is used for
  2. What you need to know before you receive COVID-19 Vaccine AstraZeneca
  3. How COVID-19 Vaccine AstraZeneca is given
  4. Possible side effects
  5. How to store COVID-19 Vaccine AstraZeneca
  6. Contents of the pack and other information

1. What COVID-19 Vaccine AstraZeneca is and what it is used for

COVID-19 Vaccine AstraZeneca is a vaccine used to protect people aged 18 years and older against COVID-19.

COVID-19 is caused by a virus called coronavirus (SARS CoV 2).

COVID-19 Vaccine AstraZeneca stimulates the body’s natural defences (immune system). It causes the body to produce its own protection (antibodies) against the virus. This will help to protect you against COVID-19 in the future. None of the ingredients in this vaccine can cause COVID-19.

2. What you need to know before you receive COVID-19 Vaccine AstraZeneca

Do not have the vaccine:

If you have ever had a severe allergic reaction to any of the active substances or any of the other ingredients listed in section 6. Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. Contact your doctor or healthcare professional immediately or go to the nearest hospital emergency room right away if you have an allergic reaction. It can be life-threatening.

If you are not sure, talk to your doctor, pharmacist or nurse.

Warnings and precautions

Tell your doctor, pharmacist or nurse before vaccination:

  • If you have ever had a severe allergic reaction (anaphylaxis) after any other vaccine injection;
  • If you currently have a severe infection with a high temperature (over 38°C).
  • However, a mild fever or infection, like a cold, are not reasons to delay vaccination;
  • If you have a problem with bleeding or bruising, or if you are taking a blood thinning medicine (anticoagulant);
  • If your immune system does not work properly (immunodeficiency) or you are taking medicines that weaken the immune system (such as high-dose corticosteroids, immunosuppressants or cancer medicines).

If you are not sure if any of the above applies to you, talk to your doctor, pharmacist or nurse before you are given the vaccine.

As with any vaccine, COVID 19 Vaccine AstraZeneca may not protect everyone who is vaccinated from COVID-19. It is not yet known how long people who receive the vaccine will be protected for. No data are currently available in individuals with a weakened immune system or who are taking chronic treatment that suppresses or prevents immune responses.

Children and adolescents

No data are currently available on the use of COVID 19 Vaccine AstraZeneca in children and adolescents younger than 18 years of age.

Other medicines and COVID 19 Vaccine AstraZeneca

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take, any other medicines or vaccines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, tell your doctor, pharmacist or nurse. There are limited data on the use of COVID-19 Vaccine AstraZeneca in pregnant or breastfeeding women. Your doctor, pharmacist or nurse will discuss with you whether you can be given the vaccine.

Driving and using machines

COVID-19 Vaccine AstraZeneca has no known effect on the ability to drive and use machines. However, side effects listed in section 4 may impact your ability to drive and use machines. If you feel unwell, do not drive or use machines.

COVID-19 Vaccine AstraZeneca contains sodium and alcohol (ethanol)

This medicine contains less than 1 mmol sodium (23 mg) per dose of 0.5 ml. This means that it is essentially ‘sodium-free’.

This medicine contains a very small amount of alcohol (2 mg of alcohol (ethanol) per dose of 0.5 ml). This is not enough to cause any noticeable effects.

3. How COVID-19 Vaccine AstraZeneca is given

COVID-19 Vaccine AstraZeneca is injected into a muscle (usually in the upper arm).

You will receive 2 injections. You will be told when you need to return for your second injection of COVID 19 Vaccine AstraZeneca.

The second injection can be given between 4 and 12 weeks after the first injection.

When COVID 19 Vaccine AstraZeneca is given for the first injection, COVID 19 Vaccine AstraZeneca (and not another vaccine against COVID 19) should be given for the second injection to complete vaccination course.

If you miss your second injection

If you forget to go back at the scheduled time, ask your doctor, pharmacist or nurse for advice. It is important that you return for your second injection of COVID-19 Vaccine AstraZeneca.

4. Possible side effects

Like all medicines, this vaccine can cause side effects, although not everybody gets them. In clinical studies with the vaccine, most side effects were mild to moderate in nature and resolved within a few days with some still present a week after vaccination.

If side effects such as pain and/or fever are troublesome, medicines containing paracetamol can be taken.

Side effects that occurred during clinical trials with COVID 19 Vaccine AstraZeneca were as follows:

Very Common (may affect more than 1 in 10 people)

  • tenderness, pain, warmth, itching or bruising where the injection is given
  • generally feeling unwell
  • feeling tired (fatigue)
  • chills or feeling feverish
  • headache
  • feeling sick (nausea)
  • joint pain or muscle ache

Common (may affect up to 1 in 10 people)

  • swelling, redness or a lump at the injection site
  • fever
  • being sick (vomiting) or diarrhoea
  • flu-like symptoms, such as high temperature, sore throat, runny nose, cough and chills

Uncommon (may affect up to 1 in 100 people)

  • feeling dizzy
  • decreased appetite
  • abdominal pain
  • enlarged lymph nodes
  • excessive sweating, itchy skin or rash

Not known (cannot be estimated from the available data)

  • severe allergic reaction (anaphylaxis)

In clinical trials there were very rare reports of events associated with inflammation of the nervous system, which may cause numbness, pins and needles, and/or loss of feeling. However, it is not confirmed whether these events were due to the vaccine.

Some people have reported a sudden feeling of cold with shivering/shaking accompanied by a rise in temperature, possibly with sweating, headache (including migraine-like headaches), nausea, muscle aches and feeling unwell, starting within a day of having the vaccine and usually lasting for a day or two.

If your fever is high and lasts longer than two or three days, or you have other persistent symptoms, this might not be due to side effects of the vaccine and you should follow appropriate advice according to your symptoms.

If you notice any side effects not mentioned in this leaflet, please inform your doctor, pharmacist or nurse.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.

If you are concerned about a side-effect it can be reported directly via the Coronavirus Yellow Card reporting site or search for MHRA Yellow Card in the Google Play or Apple App Store and include the vaccine brand and batch/Lot number if available.

By reporting side effects you can help provide more information on the safety of this vaccine.

5. How to store COVID-19 Vaccine AstraZeneca

Keep this medicine out of the sight and reach of children.

Your doctor, pharmacist or nurse is responsible for storing this vaccine and disposing of any unused product correctly.

Storage

Do not use COVID 19 Vaccine AstraZeneca after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.

Store in a refrigerator (2°C to 8°C). Do not freeze. Keep vials in outer carton to protect from light.

The vaccine does not contain any preservative and should be administered by a healthcare professional. After the first dose is withdrawn, the vaccine should be used as soon as practically possible and within 6 hours. During use it can be stored from 2°C to 25°C.

Disposal

COVID 19 Vaccine AstraZeneca contains genetically modified organisms (GMOs). Any unused vaccine or waste material should be disposed of in accordance with local requirements. Spills should be disinfected with an appropriate antiviral disinfectant.

6. Contents of the pack and other information

What COVID-19 Vaccine AstraZeneca contains

One dose (0.5 ml) contains: COVID 19 Vaccine (ChAdOx1-S* recombinant) 5 × 10^10 viral particles

*Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS CoV 2 Spike glycoprotein. Produced in genetically modified human embryonic kidney (HEK) 293 cells.

This product contains genetically modified organisms (GMOs).

The other excipients are:

  • L-histidine
  • L-histidine hydrochloride monohydrate
  • magnesium chloride hexahydrate
  • polysorbate 80
  • ethanol
  • sucrose
  • sodium chloride
  • disodium edetate dihydrate
  • water for injections

What COVID 19 Vaccine AstraZeneca looks like and contents of the pack

Solution for injection. The solution is colourless to slightly brown, clear to slightly opaque and particle free.

Pack sizes (not all pack sizes may be marketed):

  • 10 dose vial (5 ml) in packs of 10 vials
  • 8 dose vial (4 ml) in packs of 10 vials

COVID Killed 3,000 Nurses, Million of Nurses Consider Quitting the Profession.

At least 3,000 nurses have been killed by Covid-19, the global nurses’ federation said Thursday as it warned of a looming exodus of health workers traumatised by the pandemic.

Exactly one year on since the World Health Organization (WHO) first described Covid-19 as a pandemic, the International Council of Nurses said burn-out and stress had led millions of nurses to consider quitting the profession.

And once the pandemic is over, a dwindling number of experienced nurses could be left to handle the giant backlog of regular hospital care that had been postponed due to the crisis, the ICN warned.

The known death toll of nurses killed by the disease — compiled from just 60 countries — is likely to be a gross underestimate of the full total, the federation said.

ICN chief executive Howard Catton said nurses had gone through “mass traumatisation” during the pandemic, being pushed to physical and mental exhaustion.

“They reach a point where they’ve given everything they can,” he told reporters.

Catton said the global workforce of 27 million nurses was six million short going into the pandemic — and four million were heading for retirement by 2030.

‘On a precipice’
In a report, the ICN said the pandemic “could trigger a mass exodus from the profession”, from as early as the second half of 2021. The global nurse shortage could widen to nearly 13 million, it added.

“We could be on a precipice,” said Catton, recalling that it took three to four years of training to produce a novice nurse.

He said nurses had done a “phenomenal” job “to lead the world through this pandemic”, saying they would share an equal platform with the vaccine creators in the eventual history of Covid-19.

But once the pandemic has passed, frazzled nurses will then have to deal with all the unmet healthcare needs and waiting lists, whilst also facing likely staff shortages.

Founded in 1899, the ICN is a federation of more than 130 national nursing associations.

It called for governments to invest in training more new nurses to address the global shortage.

It also called for better pay to encourage existing staff to stay on — to bolster health systems for future crises, if nothing else.

Vaccination call
The WHO wants to see healthcare workers in all countries being vaccinated within the first 100 days of 2021.

Catton said that was the start line rather than the finish line, and voiced “grave concerns” at the unequal distribution of vaccines between rich and poor countries.

For nurses, facing an elevated risk of infection, immunisation “is about their right to being protected at work,” he said.

“Not being protected at work adds to their distress.”

Recalling the public appreciation shown towards nurses in the early stages of the pandemic, Catton said that now, “overwhelmingly, nurses would rather be getting their vaccine than a round of applause”.

The ICN strongly recommended that all nurses take a Covid-19 jab.

“It is an issue of protection and safety for patients,” Catton said.

“If somebody doesn’t have the vaccine then it may well be that you have to look at redeploying them to other areas.”

Source: The Guardian

How To Apply for UK Provisional and Permanent Driving Licence for Foreigners

Foreigners who come into the country from overseas might find the process of getting driving licence confusing. In this post I will simplify the process of applying for UK provisional and permanent driving licence for foreigners.

To qualify for a driving licence in the UK, you must be above the legal age of 15years and 9 months and must be a resident in the UK. You must also have a good eyesight and be able to read number plate from 20 meters away.

Method of Application

Step 1: Apply for Provisional Licence

The first step to getting a UK driving licence is to apply for provisional licence through the DVLA website https://www.gov.uk/apply-first-provisional-driving-licence

You will need your address for the last three years, some information on your international passport/British passport so it is important you get that handy, your National Insurance which is on your Biometric Residence Permit (BRP) for identity verification purpose and your credit/debit card for the payment of the application fees of £34.

Complete the application and make the payment online. You should receive an acknowledgment after this in your email. In approximately 1-2 weeks, you will receive a letter from DVLA containing a form with instruction on how to complete and submit it. If you are a foreigner, just apply your passport photograph with your name and signature at the back then proceed to the post office to send it to the address on the form. Also sign in the designated space.

You are also required to send your Biometric Residence Permit (BRP) together with the application. Your application will not be treated if you don’t send your BRP with the form. It is advisable to get a first-class self-addressed envelope at the post office and include it in the package. This will guarantee the safe return of your BRP. Summarily you will be sending the following to DVLA:

  1. The form sent to you from DVLA with your affixed passport photograph
  2. Your BRP
  3. A self-addressed first-class envelope bought from post office

Next is to patiently wait for the arrival of your temporary license. This should arrive within 2 to 4 weeks; it may take a longer time due to COVID. Your BRP may arrive first or last depending on the type of postage you use on the self-addressed envelope. During the peak of the COVID pandemic Nurses and other keyworkers are sending their forms FAO Lee Jones and getting their provisional license within 1 week. Her address is:

FAO Lee Jones

Head of Vehicle Input Services

DVLA

Longview Rd

Swansea

SA6 7JL

While waiting for your driving license, you can track your application https://www.gov.uk/track-your-driving-licence-application

Frequently asked questions

Is driving license from my home country valid in UK?

Yes, your driving license from your home country is valid for 12 months from the time you entered UK. It must however still be valid throughout the 12 months period. If at any point it becomes inactive/expired then it is no longer accepted in the UK.

I am travelling to UK compulsory to have international is it drivers’ licence?

If you have a drivers’ license duly issued by your country, you don’t need to get international drivers’ licence as your home country license is valid for 12 months in the UK.

Can I drive with my home country’s driving license without any penalty?

Yes, you can drive with your home country’s driving license within 12 months of being in the UK.

What is the list of designated countries that can change their driving license to UK license without writing any exams?

The list of designated countries is: Andorra, Australia, Barbados, British Virgin Islands, Canada, Falkland Islands, Faroe Islands, Gibraltar, Hong Kong, Japan, Monaco, New Zealand, Republic of Korea, Singapore, South Africa, Switzerland and Zimbabwe. To change your license to UK license if you are from any of these countries follow this step:

  1. Order form D1 from the Driver and Vehicle Licensing Agency (DVLA).
  2. Send the form, £43 fee and any documents you need (including your driving licence) to the address on the form.
  3. You should get your new licence within 3 weeks.

If you are from South Africa only the newly introduced credit-card style licence is accepted, the old booklet style can no longer be exchanged

You can exchange it up to 5 years after becoming resident, if it has not expired.

Nigeria Considers Bill To Address Exodus of Doctors, Nurses

A bill that would aid the reduction in numbers of Nigerians traveling for medical care and working in overseas hospitals passed second reading in the Senate

Sponsor of the “Federal Medical Centres (Establishment) Bill, 2021”, Senator Aishatu Dahiru Ahmed (APC Adamawa Central), said “an average of 20,000 Nigerians travel to India each year for medical assistance due to the absence of a solid healthcare system at home.”

Senator Ahmed noted that the piece of legislation would also sufficiently address remuneration of the employees of the Medical Centers which in turn would check the exodus of doctors and nurses to other countries.

“Seventy-seven percent of black doctors in the US are Nigerians and there is rarely any top medical institution in the US or Europe where you don’t find Nigerians managing at the top level.

“Hardly a year passes without a major national strike by nurses, doctors, or health consultants. The major reasons for these strikes are poor salaries and lack of government investment in the health sector,” she said.

The lawmaker, however, noted that the absence of a legal framework for the regulation, development and management of Federal Medical Centers to set standards for rendering health services was responsible for hindering the provision of intensive, effective and efficient health care services to the people of Nigeria.

According to her, “this has led to a number of challenges in the health sector including but not limited to under-funding, weak facilities and infrastructure, poor motivation of health workers, low budget, weak accountability, conflicts with the political structure of the states and industrial strikes which has led to inadequacies, shortcomings and weaknesses which hinder effective health care delivery services.”

Contributing to the debate, Senator Yahaya Oloriegbe (APC Kwara Central) said Federal Medical Centres were incapacitated as a result of the absence of legal backing establishing them and insufficient funding.

“We have about twenty-three Federal Medical Centres that were established across the country, but without legal backing.

“The consequence of such is that there are, what I will call policy somersault as regards the operations of these centres.

“You see some of the centres that have enough facilities and manpower to even be termed a Teaching Hospital, but because the legal framework did not state the standard, in terms of infrastructures, manpower and services, they remain like that, and it becomes at the whims and caprices of the policy makers in the Federal Ministry of Health.

“The consequences in terms of funding allocation, Federal Medical Centres receive less fund compared to Teaching Hospitals, the lawmaker said.

On his part, Senator Bala Ibn Na’Allah (APC Kebbi South) said the bill was timely as it seeks “to ensure that all institutions of government are governed by law.”

The bill after scaling Second Reading was referred by the Senate President, Ahmad Lawan, to the Committee on Health chaired by Senator Ibrahim Oloriegbe or further legislative work and to report back in four weeks.

Source: https://royalnews.com.ng/senate-considers-bill-to-address-exodus-of-doctors-nurses/

NMC CBT and OSCE Changes 2021: New Test of Competence To Start August 2021

Last year we shared our revised plans to implement the new ToC in April 2021 instead of summer 2020 due to the pressures on the health and social care sector from the Covid-19 pandemic.

The current wave of the pandemic continues to cause increasing pressure across the sector and in particular those working on the front line. We understand that asking candidates and employers to prepare for a new test at this time would add to that pressure.

We will therefore introduce the new test on 2 August 2021. Candidates will continue to sit the current ToC until this point.

We want to give you as much time as possible to become familiar with the new content, so we will publish updated resources in March. This will include the revised programme of engagement to prepare candidates, employers and recruiters for the ToC 2021.

You can find the latest information for overseas candidates in our Covid-19 hub and if you have any questions please do contact us at toc@nmc-uk.org.

With best wishes,

Linda Everet

Deputy Director, Professional Regulation

How the test will be changing

The computer-based test (CBT) will be split into two parts – Part A will cover numeracy and Part B will cover nursing or midwifery theory.

The objective structured clinical examination (OSCE) will have 10 stations:

  • Four stations will continue to be linked together around a scenario: the APIE (one station for assessment, planning, implementation and evaluation)
  • Four stations will test skills – two pairs of two skills
  • Two new stations will be introduced – one will assess the candidate’s values and behaviours and the other will assess evidence-based practice.

New OSCE marking criteria – each station will be assessed against assessed against an updated list of relevant criteria.

Updated test content – we’ve worked with clinical partners to review the existing bank of examination materials and develop new material.

Improved candidate support – we’re improving the range and quality of preparation materials for candidates and those who support them.

Trialling new CBT questions

We’re trialling some of the new CBT questions to help us decide the pass mark for the new tests.

Candidates taking the current adult nursing CBT will complete 10 extra questions. These questions will be unscored and will not count towards their CBT result, but this will help us set the pass mark for the new CBT.

We’re grateful for candidates who will be completing the 10 extra questions; we appreciate that it means more questions, however we’re confident that candidates will have enough time.

MCPDP for Nurses 2021: Katsina State MCPDP for Nurses

Another edition of the MCPDP,* organized by Katsina state MCPDP committee

NMCN Certified with 3 Continuous Education Unit (CEU)

The upcoming module is detailed hereunder .

      🍃THEME🍃

IMPROVING HEALTH THROUGH
*MATERNAL NUTRITION

👉. Module : Maternal Nutrition DATE :1st-5th March 2021
TIME* : 8 am to 4 pm daily
VENUE* : School of Nursing Katsina,
REGISTRATION: 20,000 naira payable into
Acct no: Acc no 0005489934, Katsina state MCPDP committee
Bank : access bank PLC Limited slots available.*
For payment, registration and expression of interest for slot reservation, contact this *number( calls, sms, whatsapp)
08035942730
07061098321 (Note all participants most come with facemask also most observe all covid 19 protocol in line with NCDC and State Covid 19 committee, No cash payment is allowed at any point and time so if you do so it’s at your own risk, thank you.)

JOHESU Response To NMA ‘Time To Caution Press Statetment

The attention of JOHESU has been drawn to vituperations directed against it by the loose canons who are in representative capacity at the hitherto vibrant and responsible platform called the Nigeria Medical Association (NMA).

Typical of the contemporary leadership of the NMA that we have encountered in recent years, the intellectual dwarfs who authenticated the unfortunate NMA position dwelt extensively on propaganda, threats, blackmail and other acts of skulduggery.

After our usual critical appraisal of all issues, JOHESU/AHPA wishes to posit thus on the various issues canvassed by the NMA:

  1. JOHESU as a matter of fact is a legitimate conglomerate of 5 REGISTERED Trade Unions in the Health Sector. It is a metamorphosis from our old Joint Action Committees (JAC) with a more refined and structured depth to be truly impactful.

JOHESU has made Collective Bargaining Agreements (CBA) more convenient in terms of logistics for the Federal Government (FG) and State Governments (SG) because those Governments contend with one entity instead of 5.

If the NMA spokespersons were discerning wisely, they would have known that even the courts from the NICN, High Courts, Appeal Courts and the Supreme Court which have powers to interpret the laws have always recognized JOHESU as a juristic template.

This is why it can sue and be sued. It is this stupendous ignoramus that the NMA continues to exhibit that does not allow it to know that as a mere professional body, it should not be allowed to exercise the privilege of negotiating CBAs on behalf of its membership.

The tragedy of this aberration is catalysed by their members who hold sway today at both the Federal Ministry of Health (FMOH) and Federal Ministry of Labour and Productivity (FML&P).

  1. The accusation of blackmailing the Senate and in particular Dr. Ibrahim Oloriegbe, the Chairman of Senate Committee on Health remains a figment of the imagination of the NMA hierarchy.

For the records and umpteenth time, we assert boldly and responsibly that Dr. Oloriegbe, who has complained of the tyrannical propensities of a perceived political dynasty until fate and good fortune smiled on him in the 2019 Senatorial Elections when he defeated then incumbent Senate President, Dr. Bukola Saraki has been more tyrannical than any other Medical Doctor Chairman of the Senate Committee on Health.

In the last 22 years of our democracy, at least the following, which include late Senator Martins Yellowne from Rivers West Senatorial District, Dr. Ifeanyi Okowa now Governor of Delta State, Dr. Lanre Tejuosho from Ogun Central Senatorial District have been Chairmen of the Senate Committee on Health. JOHESU/AHPA or any of the other Health professional bodies never accused these Medics of bias at hearings.

Dr. Oloriegbe stretched his misnomer at the Public Hearings he has presided on vis the NHIS Amendment Bill and the February 1, 2021 hearing by recognising his Medical Constituents above and over other stakeholders.

At the Public Hearing of February 1, 2021, JOHESU vividly declares again that Oloriegbe gave MDCN, NMA and a representative of Pathologists the floor three times spanning over fifteen minutes while professions like Pharmacy, Medical Laboratory Science, Nursing, Radiography and JOHESU representative got two minutes each to canvass their positions.

We challenge Oloriegbe and the NMA brigade to produce video and audio evidence contrary to this! The point here is Oloriegbe does not understand the philosophy and basics of running Public Hearings because he pointedly dominates discussions and debates himself while outrightly disenfranchising the stakeholders.

We must make the point that a third hearing (Public Hearing) at the National Assembly (NASS) even recognise Personal Contributions and not only group representation. Attempts to draw Oloriegbe’s attention to these facts have always been met by threats of eviction by the Sergent-at-Arms.

JOHESU therefore insists that the Senate must probe the February 1, 2021 Hearing and reorganize the Senate Committee on Health subsequently to prevent vindictive purposelessness associated with the tendencies of the NMA hierarchy as epitomized by Dr. Oloriegbe.

  1. The reference to giving birth to other Health professions by Medicine is very ridiculous. All the health professions evolved from traditional and herbal medicine.

Even if by default we accept the NMA’s claim, it is a matter of fact that the birth process by nature is sequential. One entity therefore must evolve before the other without taking away its rights and privileges like the NMA is noted for in Nigeria.

The grab-grab syndrome and know it all attitude of Nigerian Doctors is what has wrecked our Health System to become the hallmark of negative health indices as well as a wretched 187 out of 191 Health Systems globally.

We therefore have a responsibility as loyal and dynamic citizens to reverse through constructive action especially by embracing global best practices in the Health options in ultimate public interest. JOHESU will continue to uphold this without caring about who’s ox is gored.

  1. The NMA leadership in the last few years has continually excelled in clever use of untruth. It attempts to reduce very serious matters through diversionary tactics to the realm of childish harlinquinade when it brands autonomous professions as allied to Medicine. This amounts to grandeur of delusion and outright tomfoolery.

Lying to oneself is much more destructive than lying to others and we therefore encourage those who are still at such debased levels to wake and grow up to new realities in the global environment. In one template NMA says the MDCN Bill is to regulate and control ONLY Medical practitioners and Dentists. In desperation, the true intendment is to violate the domain of Medical Laboratory Sciences and Radiography. This clearly manifests in Section 4(a) which states to wit “the MDCN shall make regulations for the operation and management of Clinical Diagnostic Centres”…

In healthcare practice, who are the health professions who work and manage Clinical Diagnostic Centres which are domiciled in Clinical/Medical Laboratories or X-ray Centres as well as related facilities?

You do not have to be rich in common-sense to appreciate that this is a direct violation of the professional privileges of Medical Laboratory Scientists and Radiographers who hold sway ordinarily in these diagnostic facilities.

The NICN and several High Courts have validated the rights and powers of Medical Laboratory Scientists to take charge of the Medical Laboratory facilities through the instrumentality of the MLSCN Act, but even the FMOH aids its Medical Doctors to violate valid court orders and judgement in this regards.

Presently, the litigations have shifted to the Appellate Court at the instance of Medical Groups who are not satisfied with the plethora of court judgements against them.

We observed with dismay at the February 1, 2021 Public Hearing that when Oloriegbe was reeling out his “decree” on the rules at that hearing, he insisted references must not be made to court processes or judgements.

This is contrary to Order 41 of the Rules of Proceeding of the Senate which empowers the Senate to step down any matter that is pending in a law court when considering any Bill.

In the light of the foregoing, Section 4(9) must be expunged from the MDCN bill in its entirety in conformity with Order 41 of the Senate rules.

  1. Medical Doctors are not known to display humility even when they err in Nigeria.

After it was challenged that Doctors cannot carry the title of Apothecary because it is Pharmacists and Pharmacies that are globally Apothecaries, the NMA now says “while we may agree that the title “Apothecary” is not a title used by Doctors….. A sense of integrity should have compelled a more honourable group to accept it erred in simple terms.

As usual in the workings of propagandists, the NMA says JOHESU took a position that Medical Doctors in Nigeria should cease to use the title of Doctors which of course is fallacy.

The position of JOHESU was that any healthcare worker could assume the use of the title of “Doctor” based on a NUC approved curricula. Already, the NUC has approved a Doctor of Pharmacy and Doctor of Optometry for Pharmacists and Optometrists. Others will follow suit and so MDCN cannot and will not be allowed to legislate on a NUC jurisdiction like we shall resist in other regulatory realms where exclusivity is required for sanity.

  1. If anybody doubted the insincerity of the NMA about its intention to extend regulation and control beyond the frontiers of Medical Doctors and Dentists, then the proviso in Section 45(3)(d) and 45(3)(e) is the perfect symbol of how Medical Doctors look for trouble by standing on age-long hypocritical platitudes.

S.45(3)(d) reads Only a Registered Pharmacist shall dispense medicines prescribed by a Registered Medical Practitioner or Dental Surgeon. while Section 45(3)(e) reads Nothing in the foregoing shall preclude a Registered Medical Practitioner or Dental Surgeon or a Registered Nurse under the supervision of a Doctor or Dentist from providing medicines in the absence of a Registered Pharmacist.

Pray what is the jurisdiction of the MDCN to create rules for Pharmacists like it seeks in Section 45(3)(d) when it says the MDCN Bill is limited to Medical Doctors and Dentists?

Why did the MDCN and NMA decide to bother themselves about what should happen in the absence of a Pharmacist where they have no jurisdictional competence even in their admission that the scope of their law is for Medical Doctors and Dentists when they have not told us what should happen in the absence of Medical Doctors and Dentists which is the scope within their boundary and limitations?

The two well established Pharmacy statutes vis the Poison and Pharmacy Act and PCN Cap P.17 LFN 2004 are unambiguous about rights and privileges in sales, dispensing, procurement, importation, exportation, manufacturing, distribution and related responsibilities about drugs in Nigeria.

The PPA Cap 535 LFN in Part 3 Sections 7 and 8 makes it clear that only Registered/Licensed Pharmacists can dispense medicines. It also defines the framework for the handling of medicines in emergencies confronting Medical Doctors in Nigeria.

Section 1(1)(d) of the PCN Act which gives the PCN powers to regulate and control Pharmacy practice in all aspects and ramifications in Nigeria forbids any other regulatory agency from dabbling into Pharmacy practice in Nigeria.
More than 15 FHCs in various parts of Nigeria have affirmed that the PCN has a specific approbation in law to regulate and control Pharmacy practise in all its aspects and ramifications. In a landmark ruling of October 2007 at the FHC, Lagos in a suit by the Guild of Medical Directors vs PCN, the court declared that the PCN had a specific approbation in law to regulate and control Pharmacy practice in all its aspects and ramifications in both the public and private sectors in Nigeria. This suit is also pending at the Court of Appeal, Lagos which necessitates the need to invoke Order 41 of the Senate rules to immediately step down Sections 45(3)(d) and (e) from further consideration in the MDCN Bill.

The other reasons why Section 45(3)(d) and (e) must be expunged are:

A. The spirit of the relevant Pharmacy Acts vis the Poison & Pharmacy Act in Part III Sections 7 & 8 and the PCN Act CAP P.17 LFN 2004 in Section 1(1)(d) which gives the PCN a specific approbation in law to regulate and control Pharmacy practice in all its aspects and ramifications in Nigeria.

The Federal High Court, Lagos in a landmark ruling in October, 2007 affirmed the powers of the PCN as the ONLY body that can regulate Pharmacy Practice at both the private and public sector levels in Nigeria. The MDCN logically cannot therefore exercise the powers of the PCN to regulate Pharmacy practice through the back door.

The fall-out of this suit is also pending at the Court of Appeal.

B. Healthcare remains a global and internationally driven practice. One of the golden rules and norms in the prescribing and dispensing of drugs is that both the prescriber and the dispenser of medicines are forbidden to have pecuniary interest or gain so that the patient enjoys the best clinical decision that must be made by the prescriber.

It is interesting that in the MDCN draft bill, no consideration or thought was put in print for a next line of action in the absence of the Medical Doctor or Dentist.

Specifically, there was no clause to allow Nurses or any other practitioner to step in the shoes of the Doctor/Dentist which would have been within the jurisdiction of the MDCN. Rather strangely, the MDCN bill seeks to give Doctors/Dentists a loophole in the private sector especially to continue the many years of wreckless use of drugs through untrained hands.

This draft cannot legitimize the unlawful act of sales and dispensing of drugs by Doctors under whatever guise.

C. The scenario in (2) above is what has entrenched and formalized quackery in the Health system in Nigeria because private hospitals promote quackery through a periodic discharge of untrained elements. Such undesirable characters evolve as Auxiliary Nurses, Dispensing Assistants/Clerk etc.

D. Section 45(3)(e) in its totality will encourage the continued exploitation of the Nigerian people because WHO studies confirm pecuniary indulgences of private hospital facilities in the sales and dispensing of drugs. The study declares that prices of drugs in private hospitals is 184% above baseline prices in public hospital pharmacy and 192% above what is obtainable in private pharmacies. It is this huge profit that has always incentivized private hospital facilities to unlawfully stock drugs when they also fail to engage Pharmacists.

Moving forward, the way out remains that Doctors and private hospitals that cannot afford to engage Pharmacists should send their prescriptions to Community Pharmacies that are registered by PCN.

E. Even at Public Sector level, the greed and avarice of Medical Doctors to dabble into areas outside their core competences which led to the decapitating of the DRF scheme in public hospital pharmacies when they spend DRF funds for purposes besides drug procurement.

More daring CEOs in some FHIs actually use some naive Procurement Officers to buy drugs through proxies in our FHIs. In one of the most notorious cases, a CEO in a particular Specialist Hospital in the South East buys drugs for the Pharmacy Department, while a counterpart of his in another Specialist Hospital in the South West gave directives that drugs be moved from a Public Sector window free of charge to a Private-Public-Partnership Pharmacy window in the hospital. The South West CEO has severely disrupted the hitherto smooth flow of the drug supply chain in that FHI which was hitherto a benchmark in the proper execution of the DRF scheme today.

  1. The NMA accuses JOHESU of envy and jealousy in pedestrian and juvenile pedigree.

What is there to envy about a Nigerian Doctor? It is probably only at public sector level where Doctors have been over-indulged by the bureaucracy that they appear to earn a semblance of a living wage. Asking for equity in this regard is a legitimate and constitutional right particularly because the constitution prohibits discrimination to citizens of Nigeria.

In the private sector in Healthcare, our members excel in management of their resources than many Doctors who continue to wretched away in the Private Sector. Some of the most prominent Pharma manufacturers and importers are distinguished Pharmacists of repute. A Lady Pharmacist manufacturer in Nigeria is rated one of the 5 most prosperous female Nigerians currently. In absolute terms, no Nigerian Doctor has ever attained such heights.

One of the most successful Board room gurus in Nigeria is a Pharmacist-nonagenarian who is also a Past President of PSN.

In Medical Laboratory, some of the biggest and most notable diagnostic facilities are owned by Lab. Scientists.

It is only people who revel antiquity who imagine Doctors are benchmarks in success stories when we see what goes on in banking, oil & gas and telecoms sectors in our country.

Again we admonish NMA to get beyond these self inflicted paranoia as it will continue to inflict severe psychological atrophy on the evolution of medical practice in our land.

The attempts to portray other health-workers as dullards who want to get what they failed to get in school is lamentable.

We challenge NMA again using some of the three best Universities in Nigeria. The JAMB results at Obafemi Awolowo University (OAU), Ile-Ife was such that for the first time in recent years, Pharmacy and Medicine had the same cut-off mark. Pharmacy traditionally is higher than Medicine in that particular citadel of learning.

Surprisingly, at least to many, Nursing had a higher cut-off mark than Medicine at OAU, Ile-Ife in the current academic year. At University of Lagos (UNILAG), the cut-off mark for Pharmacy and Dentistry was same, while at University of Ibadan (UI), Pharmacy was higher than Dentistry and Veterinary Medicine.

Where is the superiority complex therefore coming from? It is just a manifestation of delusional tendencies of people who have refused to face new realities.

  1. Finally, we urge the FG to be wary of the antecedents and pedigree of persons who emerge Vice-Chancellors of our Universities.

Prof. Innocent Ujah is the pioneer VC of the Federal University of Health Sciences, Oturkpo in Benue State and President of NMA who will train persons in all the Health Sciences including Nursing, Medical Laboratory Science, Pharmacy, Medicine, Radiography, Physiotherapy and others. In good conscience, how can products of such a University studying any other course apart from Medicine evolve as confident and world class professionals under the tutelage of the man Prof. Innocent Ujah with his type of disposition?

As DG NIMR, his legacies are worth reviewing especially in terms of relationship management with other professions in that capacity.

A lot is wrong with a system that allows persons who do not have PhDs to emerge as CEOs in a purely academic world. It is probably only in Nigeria that people bag professional appointments without PhDs are appointed as VCs of Universities a phenomenon that boosts the high-handedness of medics in the public space.

For the NMA, we send word with a deep sense of conviction that we shall no longer let you get away with the foolish mentality that in the world of power there is no equality, the strong must have their way, while the weak suffer what they must like Albert Camus says.

JOHESU will champion a true agenda of health reforms which will restore order, sanity, decorum and respect for all concerned in our health system.

Comrade Joy Bio Josiah
Chairman, JOHESU